1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Xerosis (Dry Skin) Global Clinical Trials Review, H1, 2014

Xerosis (Dry Skin) Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Xerosis (Dry Skin) Global Clinical Trials Review, H1, 2014" provides data on the Xerosis (Dry Skin) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Xerosis (Dry Skin). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Xerosis (Dry Skin). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Xerosis (Dry Skin) Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Xerosis (Dry Skin) 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials 15
Clinical Trials by Phase 16
Clinical Trials by Trial Status 17
Subjects Recruited Over a Period of Time 18
Clinical Trials by Sponsor Type 19
Prominent Sponsors 20
Top Companies Participating in Xerosis (Dry Skin) Therapeutics Clinical Trials 21
Clinical Trial Profiles 22
Clinical Trial Overview of Top Companies 22
ORFAGEN 22
Clinical Trial Overview of ORFAGEN 22
Laboratoires Pierre Fabre SA 23
Clinical Trial Overview of Laboratoires Pierre Fabre SA 23
Sante Mernaud Pharmaceuticals Pvt. Ltd. 24
Clinical Trial Overview of Sante Mernaud Pharmaceuticals Pvt. Ltd. 24
L'Oreal S.A. 25
Clinical Trial Overview of L'Oreal S.A. 25
Dabur India Limited 26
Clinical Trial Overview of Dabur India Limited 26
Cosmos Pharmacies 27
Clinical Trial Overview of Cosmos Pharmacies 27
Birken AG 28
Clinical Trial Overview of Birken AG 28
ALK-Abello A/S 29
Clinical Trial Overview of ALK-Abello A/S 29
Clinical Trial Overview of Top Institutes / Government 30
Japan Health and Research Institute 30
Clinical Trial Overview of Japan Health and Research Institute 30
University of the Philippines Diliman 31
Clinical Trial Overview of University of the Philippines Diliman 31
National Cancer Center Hospital East 32
Clinical Trial Overview of National Cancer Center Hospital East 32
Rutgers, The State University of New Jersey 33
Clinical Trial Overview of Rutgers, The State University of New Jersey 33
Kyoto University 34
Clinical Trial Overview of Kyoto University 34
Five Key Clinical Profiles 35
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 53
Contact Us 53
Disclaimer 53
Source 53

List of Tables
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Region, 2014* 6
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Xerosis (Dry Skin) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Xerosis (Dry Skin) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Xerosis (Dry Skin) Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials, G7 Countries (%), 2014* 12
Xerosis (Dry Skin) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Xerosis (Dry Skin) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials, E7 Countries (%), 2014* 15
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 18
Xerosis (Dry Skin) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 19
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 20
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 21
Xerosis (Dry Skin) Therapeutics Clinical Trials Market, Global, Clinical Trials by ORFAGEN, 2014* 22
Xerosis (Dry Skin) Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2014* 23
Xerosis (Dry Skin) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sante Mernaud Pharmaceuticals Pvt. Ltd., 2014* 24
Xerosis (Dry Skin) Therapeutics Clinical Trials Market, Global, Clinical Trials by L'Oreal S.A., 2014* 25
Xerosis (Dry Skin) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dabur India Limited, 2014* 26
Xerosis (Dry Skin) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cosmos Pharmacies, 2014* 27
Xerosis (Dry Skin) Therapeutics Clinical Trials Market, Global, Clinical Trials by Birken AG, 2014* 28
Xerosis (Dry Skin) Therapeutics Clinical Trials Market, Global, Clinical Trials by ALK-Abello A/S, 2014* 29
Xerosis (Dry Skin) Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Health and Research Institute, 2014* 30
Xerosis (Dry Skin) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of the Philippines Diliman, 2014* 31
Xerosis (Dry Skin) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center Hospital East, 2014* 32
Xerosis (Dry Skin) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rutgers, The State University of New Jersey, 2014* 33
Xerosis (Dry Skin) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2014* 34

List of Figures
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Xerosis (Dry Skin) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Xerosis (Dry Skin) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials, G7 Countries (%), 2014* 12
Xerosis (Dry Skin) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Xerosis (Dry Skin) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials, E7 Countries (%), 2014* 15
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 18
Xerosis (Dry Skin) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 19
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 20
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 21
GlobalData Methodology 52

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.